Voluven 6%

• 6% hydroxyethyl starch 130/0.4 in 0,9% sodium chloride solution
• Derived from waxy maize starch (potato starch is not bioequivalent*)
• Iso-oncotic solution – suitable for volume replacement
• Provides both initial and medium-term volume effects (4-6 h)
• Millions of patients worldwide treated since 1999
• Supported by extensive clinical evidence

500 ml Polyolefine bag (free flex)

Voluven® is indicated for the treatment and prophylaxis of hypovolaemia in adults and children. It is not a substitute for red blood cells or coagulation factors in plasma.

Hypovolaemia
Hypovolaemia is associated with disturbances in macro- and microcirculation.

Macro- and microcirculation disturbances give rise to diminished organ blood flow and decreased oxygen supply to various organs, and finally to functional organ failure.

• Adult Dose
• upto 50 ml/kg (bw)/day
• Paediatric Dose
• Newborn-infants (<2 years)
• *A mean dose of 16±9 ml/ kg (bw)/ day
• Children (2-12 years)
• *A mean dose of 36± 11 ml/kg (bw)/day